The University of Kentucky Research Foundation has been awarded a $612,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) from the Defense Health Agency. The grant will fund the development of a new personalized medicine model for high-risk pediatric sarcomas, with a performance period from August 1, 2024 to July 31, 2026. As the prime awardee, the Research Foundation will leverage its expertise in biomedical research and collaborative partnerships to advance innovative treatments for this challenging pediatric cancer. The federal grant supports the Research Foundation's mission to facilitate multidisciplinary research projects that address critical healthcare needs, including those relevant to military personnel and veterans.
Generated 3/4/25, 7:39 AM